Тактика при отсутствии эффекта от лечения
Рекомендуется назначение других препаратов или методик (курсовых) лечения.
При рецидивирующем течении заболевания рекомендовано применение интерферона системного действия - интерферона гамма 500000 МЕ 1 раз в сутки подкожно через день, на курс 5 инъекций (В) [28-30].
СПИСОК ЛИТЕРАТУРЫ.
1. Nilsen AE, AasenT, Halsos AM, et al. Efficacy of oral aciclovir in the treatment of initial and recurrent genital herpes. Lancet 1982;ii:571-3
2. Spruance SL, Tyring TK, DeGregorio B, Miller C, Beutner K and the Valaciclovir study group. A large-scale, placebo controlled, dose ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996;156:1729-35.
3. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD, for the Canadian Famciclovir Study. Patient-initiated, twice daily, oral famciclovir for early recurrent genjnital herpes: a randomized, double-blind multicenter trial. JAMA 1996;276:44-9
4. Corey L, Benedetti J, Critchlow C, et al. Treatment of primary first-episode genital herpes simplex virus infections with aciclovir: results of topical, intravenous and oral therapy. J Antimicrob Chemother 1983;12(suppl B):79-88.
5. Fife KH, Barbarash RA, Rudolph T, DeGregorio B, Roth R. Valaciclovir versus aciclovir in the treatment of first-episode genital herpes infection. Results of an international multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis1997;24:481-6.
6. Mertz GJ. Management of genital herpes. Adv Exp Med Biol. 1996;394:1-10. Review.
7. Wald A, Carrell D, Remington M, et al. Two-day regiment of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002 34(7):944-8
8. Aoki FY, Tyring S, Diaz-Mitoma F, Gross G, Gao J, Hamed K. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebocontrolled trial. Clin Infect Dis 2006;42:8-13
9. Abudalu M, Tyring S, Koltun W, Bodsworth N, Hamed K. Single-day. patient-initiated famciclovir therapy versus 3-day valaciclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial. Clin Infect Dis 2008;47:651-8
10. Leone PA, Trottier S, Miller JM. Valaciclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-62.
11. Strand A, Patel R, Wulf HC, Coates KM and The International Valaciclovir Study Group. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir. Sex Transm Infect 2002;78:435-9
12. Bodsworth N, Bloch M, McNulty A, 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study, Sexual Health 2008 5(3)219-225
13. Рахматулина М.Р. Эпизодическая терапия рецидивирующей герпетической инфекции: результаты проспективного постмаркетингового исследования. Вестник дерматологии и венерологии. – 2009. - №5. – С. 120-124.
14. Lebrun-Vignes B et al. A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks.JAm Acad Dermatol 2007;57:238-46
15. Geretti AM. Genital herpes. Sex Transm Infect 2006;82 Suppl 4:iv31-4.
16. Mertz GJ, Jones CC, Mills J et al. Long-term aciclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 1988;260:201-6
17. Mindel A, Faherty A, Carney O, Patou G, Freris M, Williams P. Dosage and safety of longterm suppressive aciclovir therapy for recurrent genital herpes. Lancet 1988;331:926-8
18. Corey L, Wald A, Patel R et al. Once-daily valaciclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004;350:11-20
19. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol. 2003;102(6):1396–1403.
20. Watts DH, Brown ZA, Money D, et al. A doubleblind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of Herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol. 2003;188(3):836–843
21. Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent recurrent genital herpes at delivery. Infect Dis Obstet Gynecol. 2002;10(2):71–77
22. Brocklehurst P, Kinghorn G, Carney O, et al. A randomised placebo-controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol. 1998; 105(3):275–280
23. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol. 1996;87(1):69–73
24. Braig S, Luton D, Sibony O, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):55–58
25. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplx virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews 2008, Issue 1
26. A. M. Kesson, “Management of neonatal herpes simplex virus infection,” Paediatric Drugs, vol. 3, no. 2, pp. 81–90, 2001. View at Scopus
27. Cantin E, Tanamachi B., Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 1999; 73: 3418-3423
28. Sainz B. Jr., Halford W.P.(2002) Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J. Virol., 76(22): 11541–11550.
29. Рахматулина М.Р. Интерферон-гамма в терапии генитального герпеса // Инфекционные болезни. - 2007. - № 3. - С. 76-79.
30. Sundmacher R., Mattes A., Neumann-Haefelin D. et al.(1987) The potency of interferon-alpha 2 and interferon-gamma in a combination therapy of dendritic keratitis. A controlled clinical study. Curr. Eye Res., 6(1): 273–276.